PineBridge GEM II Amends IBEX Ltd. Stake Filing

TL;DR

PineBridge updated its IBEX filing, still watching their stake.

AI Summary

PineBridge GEM II G.P., L.P. filed an amendment (No. 3) to its Schedule 13D on November 22, 2024, regarding its holdings in IBEX Ltd. The filing indicates a change in the date as of which the information is reported to November 22, 2024. No specific new share counts or dollar amounts were detailed in this amendment, but it signifies an ongoing disclosure requirement for significant shareholders.

Why It Matters

This filing is an update to a previous disclosure by a significant shareholder, indicating continued monitoring and potential activity related to IBEX Ltd.'s stock.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, making them relevant for assessing potential market impact.

Key Players & Entities

• PineBridge GEM II G.P., L.P. (company) — Filing person
• IBEX Ltd (company) — Subject company
• William Corson (person) — Person authorized to receive notices

FAQ

Key Financial Figures

• $0.0001 — e of Issuer) Common Shares, par value $0.0001 (Title of Class of Securities) G4690

Filing Documents

• 13da3foribex.htm (SC 13D/A) — 164KB
• ex9.htm (EX-9) — 12KB
• 0000905148-24-003263.txt ( ) — 178KB

of the Schedule 13D is hereby amended and supplemented as follows

Item 1 of the Schedule 13D is hereby amended and supplemented as follows: This Amendment No. 3 to Schedule 13D ("Amendment No. 3") is being filed by the undersigned, pursuant to 240.13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on January 5, 2022, as amended by Amendment No. 1 filed with the SEC on September 17, 2024 and Amendment No. 2 filed with the SEC on October 4, 2024 (collectively, the "Schedule 13D"), with respect to the common shares, $0.0001 par value (the "Common Shares"), of IBEX Limited (the "Issuer"), whose principal executive offices are located at 1717 Pennsylvania Avenue NW, Suite 825, Washington, DC 20006. Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 3 shall have the meanings given to them in the Schedule 13D. Item 4. Purpose of Transaction

of the Schedule 13D is hereby amended and supplemented as follows

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On October 24, 2024, Mr. Leone resigned from the board of directors of the Issuer. Item 5. Interest in Securities of the Issuer

(a) - (c) of the Schedule 13D is hereby amended and supplemented as follows

Item 5(a) - (c) of the Schedule 13D is hereby amended and supplemented as follows: (a) GEM II is the record owner of 1,571,739 Common Shares. As the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II, GEM II GP may be deemed to beneficially own the Common Shares directly owned by GEM II. As members of the Investment Committee, each of the Investment Committee Members may be deemed to beneficially own the Common Shares directly owned by GEM II. PineBridge GEM II G.P., Co., a Cayman Islands company, is the sole general partner of GEM II GP. PineBridge GEM II G.P., Co. is a wholly-owned subsidiary of PineBridge Investments Partners LLC, a Delaware limited liability company that is a wholly-owned subsidiary of PineBridge Investments, L.P., a Cayman Islands partnership ("PILP"). The General Partner of PILP is Bridge Holdings Company Limited ("Bridge Holdings"). Bridge Holdings is wholly owned by Pacific Century Investment Holdings No. 1 Limited ("PCIH No. 1"). PCIH No. 1 is wholly owned by ChiltonLink Limited, which, in turn, is wholly owned by Richard Li. Each of PineBridge GEM II G.P., Co., PineBridge Investments Partners LLC, PILP, Bridge Holdings, PCIH No. 1, ChiltonLink Limited, and Richard Li. disclaims beneficial ownership of the Common Shares directly owned by GEM II. The percentage of outstanding Common Shares of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on 16,764,808 Common Shares outstanding as of October 31, 2024, as reported on the Issuer's quarterly report on Form 10-Q filed with the SEC on November 7, 2024, minus 3,562,341 Common Shares that the Issuer repurchased on November 19, 2024, as reported in the Issuer's current report on Form 8-K filed with the SEC on November 20, 2024. (b) Regarding the number of shares as to which such person has: (i) sole power to vote or to

of the Schedule 13D is hereby amended and supplemented as follows

Item 7 of the Schedule 13D is hereby amended and supplemented as follows: Exhibit 9 Schedule of Transactions for Item 5(c) of Amendment No. 3. CUSIP No: G4690M101 SCHEDULE 13D Page 8 of 8 Pages SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. EXECUTED this 22nd day of November, 2024. PINEBRIDGE GLOBAL EMERGING MARKETS PARTNERS II, L.P. By: PINEBRIDGE GEM II GP Ltd., its General Partner By: PINEBRIDGE GEM II G.P., L.P., its Sole Director By: PINEBRIDGE GEM II G.P., Co., its General Partner By: /s/ John Leone Name: John Leone Title: Vice President PINEBRIDGE GEM II G.P., L.P. By: PINEBRIDGE GEM II G.P., Co., its General Partner By: /s/ John Leone Name: John Leone Title: Vice President /s/ John Leone John Leone * Pierre Mellinger * Kevin Clowe */s/ Lindsay Johnson Lindsay Johnson As attorney-in-fact *This Schedule 13D was executed by Lindsay Johnson on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as an exhibit to the amendment to Form 3 filed by GEM II, GEM II GP, Mr. Mellinger and Mr. Clowe on July 13, 2023. Attention: Intentional misstatements or omissions of fact constitute federal violations (see 18 U.S.C. 1001).

View Full Filing

View this SC 13D/A filing on SEC EDGAR